HYQVIA, the only once-a-month Subcutaneous (SubQ) Immunoglobulin (Ig)1
HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] is a subcutaneous immunoglobulin that can be administered using 1 needle, 1 infusion site, 1 time a month in the comfort of your home or your healthcare professional's office, clinic or hospital.
The frequency and number of infusion sites can be adjusted based on the patient's clinical response, taking into consideration volume, total infusion time, and tolerability.
HYQVIA is an immune globulin with a Recombinant Human Hyaluronidase indicated for the treatment of Primary Immunodeficiency (PI) in adults. This includes, but is not limited to, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
Limitation of Use:
Safety and efficacy of chronic use of Recombinant Human Hyaluronidase in HYQVIA have not been established in conditions other than PI.
HYQVIA Training Kit
The HYQVIA Training Kit includes a step-by-step guide, product brochure, infusion log, and a sling bag to make the transition to HYQVIA as simple as possible.
Your doctor will determine if self-infusion of HYQVIA is appropriate for you. Do not self-infuse until you or your caregiver have received training by your doctor.
Call MyIgSource at 1-855-250-5111 to order the Training Kit.
Visit HYQVIA.com to learn more about HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase]Visit Site
We've got eligible patients with Primary Immunodeficiency (PI) covered!
Learn more about the MyIgCopayCard Program here.